Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2341-22-2

Post Buying Request

2341-22-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2341-22-2 Usage

Description

5-Fluorocytidine is a synthetic nucleoside analog that is structurally similar to the natural nucleoside cytidine. It is a white powder and is known for its potential applications in various fields due to its unique chemical properties.

Uses

Used in Pharmaceutical Industry:
5-Fluorocytidine is used as an antiviral and anticancer agent for its ability to inhibit the synthesis of viral and tumor DNA. It is particularly effective against RNA viruses and certain types of cancer cells, making it a valuable compound in the development of new therapeutic strategies.
Used in Research Applications:
5-Fluorocytidine is used as a probe for studying RNA structure through 19F-NMR spectroscopy. This application allows researchers to gain insights into the molecular interactions and dynamics of RNA molecules, which can be crucial for understanding various biological processes and developing targeted therapies.
Used in Drug Development:
5-Fluorocytidine serves as a key intermediate in the synthesis of other therapeutically relevant compounds, such as 5-fluorouracil and other 5-fluoropyrimidine nucleotides. These compounds have been widely used in the treatment of various types of cancer, making 5-Fluorocytidine an essential component in the development of novel anticancer drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 2341-22-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,4 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2341-22:
(6*2)+(5*3)+(4*4)+(3*1)+(2*2)+(1*2)=52
52 % 10 = 2
So 2341-22-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H8FNO2/c9-6-4-2-1-3-5(6)7(10)8(11)12/h1-4,7H,10H2,(H,11,12)

2341-22-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (F0534)  5-Fluorocytidine  >97.0%(T)

  • 2341-22-2

  • 1g

  • 890.00CNY

  • Detail
  • TCI America

  • (F0534)  5-Fluorocytidine  >97.0%(T)

  • 2341-22-2

  • 5g

  • 2,890.00CNY

  • Detail
  • Aldrich

  • (543020)  5-Fluorocytidine  97%

  • 2341-22-2

  • 543020-1G

  • 852.93CNY

  • Detail

2341-22-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-fluorocytidine

1.2 Other means of identification

Product number -
Other names 5-Fluorocytidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2341-22-2 SDS

2341-22-2Synthetic route

1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-fluorocytosine
53294-73-8

1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-fluorocytosine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With ammonia In methanol at 20℃;92%
2',3',5'-tri-O-acetyl-4-O-methyl-5-fluorouridine
175651-04-4

2',3',5'-tri-O-acetyl-4-O-methyl-5-fluorouridine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With methanol; ammonia Ambient temperature;81%
(2R,3R,3aS,9aR)-2-Hydroxymethyl-6-imino-2,3,3a,5,6,9a-hexahydro-4aH-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ol

(2R,3R,3aS,9aR)-2-Hydroxymethyl-6-imino-2,3,3a,5,6,9a-hexahydro-4aH-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ol

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With sodium hydrogencarbonate In N,N-dimethyl-formamide80.9%
2',3',5'-tri-O-acetyl-5-fluorocytidine
128963-10-0

2',3',5'-tri-O-acetyl-5-fluorocytidine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With ammonia In methanol55%
4-Amino-5-fluoro-1-((4aR,6R,7R,7aR)-7-hydroxy-2-oxo-tetrahydro-2λ4-furo[3,2-d][1,3,2]dioxathiin-6-yl)-1H-pyrimidin-2-one

4-Amino-5-fluoro-1-((4aR,6R,7R,7aR)-7-hydroxy-2-oxo-tetrahydro-2λ4-furo[3,2-d][1,3,2]dioxathiin-6-yl)-1H-pyrimidin-2-one

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With sodium hydrogencarbonate In N,N-dimethyl-formamide49.2%
1-(β-D-xylofuranosyl)-5-fluorocytosine
669055-50-9

1-(β-D-xylofuranosyl)-5-fluorocytosine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Stage #1: 1-(β-D-xylofuranosyl)-5-fluorocytosine With thionyl chloride In acetonitrile at 25℃;
Stage #2: With sodium hydrogencarbonate In N,N-dimethyl-formamide at 105℃; for 3h;
49.2%
Multi-step reaction with 2 steps
1: SOCl2 / acetonitrile
2: 49.2 percent / NaHCO3 / dimethylformamide
View Scheme
2',3',5'-tri-O-acetyl-5-fluorouridine
55474-11-8

2',3',5'-tri-O-acetyl-5-fluorouridine

A

5-fluorouridine
316-46-1

5-fluorouridine

B

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Yield given. Multistep reaction. Yields of byproduct given;
4-N-2',3',5'-O-tetraacetylcytidine
5040-18-6

4-N-2',3',5'-O-tetraacetylcytidine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With Dowex 50x2; fluorine; acetic acid Yield given. Multistep reaction;
1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-fluoro-uracil
2560-60-3

1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-fluoro-uracil

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
With ammonia In methanol at 20℃; for 24h;
1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose
14215-97-5

1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hexamethyldisilazane / toluene / 3 h / Heating
1.2: 91 percent / TMS-triflate / 1,2-dichloro-ethane / 8 h / 20 °C
2.1: 92 percent / NH3 / methanol / 20 °C
View Scheme
5-fluorouridine
316-46-1

5-fluorouridine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 76 percent / Et3N; DMAP / pyridine / 6 h / 20 °C
2: NH3 / methanol / 24 h / 20 °C
View Scheme
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
55474-11-8

(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) 1,2,4-triazole, 4-chlorophenylphosphorodichloride, 2.) DBU / 1.) Py, 110 h, 2.) 15 min, rt
2: 81 percent / ammonia/methanol / Ambient temperature
View Scheme
2',3',5'-tri-O-acetyl-5-fluorouridine
55474-11-8

2',3',5'-tri-O-acetyl-5-fluorouridine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
2: 70 percent / conc. aq. NH3 / dioxane / 1 h
3: 55 percent / NH3 / methanol
View Scheme
2',3',5'-tri-O-acetyl-uridine
4105-38-8

2',3',5'-tri-O-acetyl-uridine

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 98 percent / F2/N2 (20/80) / acetic acid / 0.5 h
3: 70 percent / conc. aq. NH3 / dioxane / 1 h
4: 55 percent / NH3 / methanol
View Scheme
5-Fluor-4-tetrazolo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1(2H)-pyrimidinon
128963-07-5

5-Fluor-4-tetrazolo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1(2H)-pyrimidinon

5-fluorocytidine
2341-22-2

5-fluorocytidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70 percent / conc. aq. NH3 / dioxane / 1 h
2: 55 percent / NH3 / methanol
View Scheme
O-benzylhydoxylamine hydrochloride
2687-43-6

O-benzylhydoxylamine hydrochloride

5-fluorocytidine
2341-22-2

5-fluorocytidine

N4-[O-(benzyloxy)]-5-fluorocytidine

N4-[O-(benzyloxy)]-5-fluorocytidine

Conditions
ConditionsYield
With pyridine at 80℃; for 12h;83%
5-fluorocytidine
2341-22-2

5-fluorocytidine

5-fluoro-N4-hydroxycytidine
402725-26-2

5-fluoro-N4-hydroxycytidine

Conditions
ConditionsYield
With hydroxylamine hydrochloride; sodium hydroxide In water at 55℃; for 16h; pH=5; Sealed tube; Inert atmosphere;24%
With hydroxylamine hydrochloride In water at 55℃; for 16h; pH=5; Sealed tube; Inert atmosphere;24%
In water at 55℃; for 16h; pH=5; Sealed tube; Inert atmosphere;24%
triethylamine carbonate
15715-58-9

triethylamine carbonate

5-fluorocytidine
2341-22-2

5-fluorocytidine

5-fluoro-CTP tetrakistriethylammonium salt

5-fluoro-CTP tetrakistriethylammonium salt

Conditions
ConditionsYield
Stage #1: 5-fluorocytidine With trimethyl phosphite; N,N,N',N'-tetramethyl-1,8-diaminonaphthalene at 0℃; for 0.166667h;
Stage #2: With trichlorophosphate for 2h; Inert atmosphere;
Stage #3: triethylamine carbonate Further stages;
20%
triethylamine carbonate
15715-58-9

triethylamine carbonate

5-fluorocytidine
2341-22-2

5-fluorocytidine

5-fluoro-CTP tetrakis(triethylammonium) salt

5-fluoro-CTP tetrakis(triethylammonium) salt

Conditions
ConditionsYield
Stage #1: 5-fluorocytidine With N,N,N',N'-tetramethyl-1,8-diaminonaphthalene at 0℃; for 0.166667h;
Stage #2: With trichlorophosphate for 2h; Inert atmosphere;
Stage #3: triethylamine carbonate Further stages;
20%
(S)-2-[(S)-(2,3,4,5,6-pentafluoro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester
1337529-56-2

(S)-2-[(S)-(2,3,4,5,6-pentafluoro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester

5-fluorocytidine
2341-22-2

5-fluorocytidine

C21H28FN4O9P

C21H28FN4O9P

Conditions
ConditionsYield
Stage #1: 5-fluorocytidine With isopropylmagnesium chloride In tetrahydrofuran at 0 - 20℃; for 0.5h; Schlenk technique; Inert atmosphere;
Stage #2: (S)-2-[(S)-(2,3,4,5,6-pentafluoro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester In tetrahydrofuran at 0 - 20℃; Schlenk technique; Inert atmosphere;
10.9%
P,P'-methanediyl-bis-phosphonic acid tetrachloride
1499-29-2

P,P'-methanediyl-bis-phosphonic acid tetrachloride

triethylamine carbonate
15715-58-9

triethylamine carbonate

5-fluorocytidine
2341-22-2

5-fluorocytidine

5-fluorocytidine-5'-O-[(phosphonomethyl)phosphonic acid] sesquitriethylamine salt

5-fluorocytidine-5'-O-[(phosphonomethyl)phosphonic acid] sesquitriethylamine salt

Conditions
ConditionsYield
Stage #1: P,P'-methanediyl-bis-phosphonic acid tetrachloride; 5-fluorocytidine at 0℃; for 0.5h;
Stage #2: triethylamine carbonate With water at 0 - 20℃; for 0.75h; pH=8.4 - 8.6;
7%
2-acetoxy-2-methylpropanoyl chloride
40635-66-3

2-acetoxy-2-methylpropanoyl chloride

5-fluorocytidine
2341-22-2

5-fluorocytidine

(3aS)-3c-acetoxy-7-fluoro-2t-hydroxymethyl-(3ar,9ac)-2,3,3a,9a-tetrahydro-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-ylideneamine
60827-80-7

(3aS)-3c-acetoxy-7-fluoro-2t-hydroxymethyl-(3ar,9ac)-2,3,3a,9a-tetrahydro-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-ylideneamine

Conditions
ConditionsYield
In acetonitrile
5-fluorocytidine
2341-22-2

5-fluorocytidine

(3aS)-7-fluoro-2t-hydroxymethyl-6-imino-(3ar,9ac)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3c-ol
37717-21-8

(3aS)-7-fluoro-2t-hydroxymethyl-6-imino-(3ar,9ac)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3c-ol

Conditions
ConditionsYield
With water; trichlorophosphate In ethyl acetate
L-dipalmitoylphosphatidylcholine
63-89-8

L-dipalmitoylphosphatidylcholine

5-fluorocytidine
2341-22-2

5-fluorocytidine

C44H78FN3O12P(1-)*Na(1+)
116661-29-1

C44H78FN3O12P(1-)*Na(1+)

Conditions
ConditionsYield
With acetate buffer; Diaion WK-20 resin ; calcium chloride; phospholipase D-P 1.) H2O, CHCl3, 45 deg C, 6 h, pH 5.6, 2.) CHCl3, MeOH, H2O; Yield given. Multistep reaction;
5-fluorocytidine
2341-22-2

5-fluorocytidine

O2,2'-cyclo-β-D-arabinofuranosyl-5-fluorocytosine

O2,2'-cyclo-β-D-arabinofuranosyl-5-fluorocytosine

Conditions
ConditionsYield
Yield given. Multistep reaction;
5-fluorocytidine
2341-22-2

5-fluorocytidine

5-fluoro-1-(β-D-arabinofuranosyl)cytosine
4298-10-6

5-fluoro-1-(β-D-arabinofuranosyl)cytosine

Conditions
ConditionsYield
Yield given. Multistep reaction;
N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

5-fluorocytidine
2341-22-2

5-fluorocytidine

N'-[1-(2-dimethylamino-6-hydroxymethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl]-N,N-dimethyl-formamidine

N'-[1-(2-dimethylamino-6-hydroxymethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl]-N,N-dimethyl-formamidine

Conditions
ConditionsYield
With pyridine at 20℃; for 15h;
5-fluorocytidine
2341-22-2

5-fluorocytidine

N'-{1-[2-dimethylamino-6-(4-oxo-4H-benzo[1,3,2]dioxaphosphinin-2-yloxymethyl)-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine

N'-{1-[2-dimethylamino-6-(4-oxo-4H-benzo[1,3,2]dioxaphosphinin-2-yloxymethyl)-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 15 h / 20 °C
2: pyridine / dioxane / 0.17 h / 20 °C
View Scheme
5-fluorocytidine
2341-22-2

5-fluorocytidine

N'-{1-[6-(4,6-dihydroxy-4,6-dioxo-4λ5,6λ5-[1,3,5,2,4,6]trioxatriphosphinan-2-yloxymethyl)-2-dimethylamino-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine

N'-{1-[6-(4,6-dihydroxy-4,6-dioxo-4λ5,6λ5-[1,3,5,2,4,6]trioxatriphosphinan-2-yloxymethyl)-2-dimethylamino-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine / 15 h / 20 °C
2: pyridine / dioxane / 0.17 h / 20 °C
3: tributylammonium pyrophosphate; (n-Bu)3N / dimethylformamide / 0.17 h
View Scheme
5-fluorocytidine
2341-22-2

5-fluorocytidine

5'-O-(1-thio)-5-fluorocytidine triphosphate

5'-O-(1-thio)-5-fluorocytidine triphosphate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: pyridine / 15 h / 20 °C
2: pyridine / dioxane / 0.17 h / 20 °C
3: tributylammonium pyrophosphate; (n-Bu)3N / dimethylformamide / 0.17 h
4: sulfur / dimethylformamide / 0.17 h / 20 °C
5: concd. NH4OH; NH4OAc / 0.5 h / 50 °C
View Scheme
5-fluorocytidine
2341-22-2

5-fluorocytidine

N'-{1-[6-(4,6-dihydroxy-4,6-dioxo-2-thioxo-2λ5,4λ5,6λ5-[1,3,5,2,4,6]trioxatriphosphinan-2-yloxymethyl)-2-dimethylamino-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine

N'-{1-[6-(4,6-dihydroxy-4,6-dioxo-2-thioxo-2λ5,4λ5,6λ5-[1,3,5,2,4,6]trioxatriphosphinan-2-yloxymethyl)-2-dimethylamino-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-5-fluoro-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: pyridine / 15 h / 20 °C
2: pyridine / dioxane / 0.17 h / 20 °C
3: tributylammonium pyrophosphate; (n-Bu)3N / dimethylformamide / 0.17 h
4: sulfur / dimethylformamide / 0.17 h / 20 °C
View Scheme

2341-22-2Relevant articles and documents

A simple and efficient synthesis of puromycin, 2,2′-anhydro- pyrimidine nucleosides, cytidines and 2′,3′-anhydroadenosine from 3′,5′-O-sulfinyl xylo-nucleosides

Takatsuki, Ken-Ichi,Ohgushi, Sumito,Kohmoto, Shigeo,Kishikawa, Keiki,Yamamoto, Makoto

, p. 719 - 734 (2007/10/03)

Synthesis of antibiotics, puromycin and 3 ′-amino-3 ′-deoxy-N 6 ,N 6 -dimethyladenosine 11 was achieved by utilizing the cyclic sulfite 6a of the xylo -3 ′,5 ′-dihydroxy group as a new protective group. The key synthetic step is the deprotection of the sulfite moiety through the intramolecular cyclization of 2-α-carbamate 7 . In a similar manner, 2,2 ′-anhydro-pyrimidine nucleosides 15 , ribo -cytidines 17 and 2 ′,3 ′-anhydroadenosine 14 were prepared in high yields from the corresponding sulfites 4 , 5 , and 6b , respectively. Copyright Taylor & Francis Group, LLC.

A new protecting group '3′,5′-O-sulfinyl' for xylo-nucleosides. A simple and efficient synthesis of 3′-amino-3′-deoxyadenosine (a puromycin intermediate), 2,2′-anhydro-pyrimidine nucleosides and 2′,3′-anhydro-adenosine

Takatsuki, Ken-Ichi,Yamamoto, Makoto,Ohgushi, Sumito,Kohmoto, Shigeo,Kishikawa, Keiki,Yamashita, Haruhiro

, p. 137 - 140 (2007/10/03)

We developed a new protecting group, the cyclic sulfite for the protection of the 3′,5′-dihydroxy group of nucleosides. Seven cyclic sulfites, 4a-c, 5a-b, and 6a-b were prepared in high yields from the corresponding xylo-uridines 1 and 2, and xylo-adenosines 3 with thionyl chloride, respectively. Synthesis of the puromycin intermediate 8 was carried out by deprotection of the sulfite moiety through an intramolecular cyclization of the 2′-α-carbamate 7.

Biochemical detection of cytidine protonation within RNA

Oyelere,Strobel

, p. 10259 - 10267 (2007/10/03)

Perturbation of active site functional group pK(a)s is an important strategy employed by protein enzymes to achieve catalysis. There is increasing evidence to indicate that RNAs also utilize functional group pK(a) perturbation for folding and reactivity. One of the best candidates for a functionally relevant pK(a) perturbation is the N3 of C (pK(a) 4.2), which could be sufficiently raised to allow protonation near physiological pH. Here we report the synthesis and use of a series of α-phosphorothioate tagged cytidine analogues whose altered N3 pK(a)s make it possible to efficiently detect functionally relevant protonation events by nucleotide analogue interference mapping. 6-Azacytidine (n6CαS) and 5-fluorocytidine (f5CαS) both have enhanced acidity at the N3 position (pK(a) 2.6 and 2.3, respectively) but leave the hydrogen bonding face of C otherwise unaffected. In contrast, pseudoisocytidine (ΨiCαS) is a charge neutral analogue that mimics the hydrogen bonding character of protonated C. To test the utility of these analogues, we characterized the C300+-G97-C277 mutant form of the Tetrahymena group I intron, which is predicted to require C300 protonation for ribozyme folding and reactivity. At neutral to alkaline pHs, C300 was the only site of n6CαS and f5Cαs interference within the intron, yet both interferences were rescued at acidic pH. Furthermore, ΨiCαS substitution at C300 resulted in enhanced activity at alkaline pHs, consistent with the presence of an N3 proton under the pH conditions studied. Interference mapping with these analogues provides an efficient and sensitive means to identify every site within an RNA where cytidine protonation is important for RNA function and may make it possible to identify C's that participate in general acid/base catalysis within ribozyme active sites.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2341-22-2